IFNA1 and neoplasm: Locally increased IFN signaling within the TME reverses the suppressive mechanisms and induces antitumor immunity/tumor regression,28 while additional IFN therapy increases the cytolytic activity of T cells in vivo and increases cytotoxic T-lymphocyte activity.28